Inhibition of dengue virus entry into target cells using synthetic antiviral peptides
Despite the importance of DENV as a human pathogen, there is no specific treatment or protective vaccine. Successful entry into the host cells is necessary for establishing the infection. Recently, the virus entry step has become an attractive therapeutic strategy because it represents a barrier to...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638295/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638295/ |